Medtronic (NYSE: MDT) announced that it received FDA approval for its OmniaSecure defibrillation lead for right ventricle ...

Medtronic said its OmniaSecure device can be used to treat potentially life-threatening conditions including ventricular tachyarrhythmias, a heart rhythm disorder where the heart's lower chambers beat ...

Medtronic (MDT) received U.S. Food and Drug Administration approval for the OmniaSecure defibrillation lead for placement within the right ...

Seth Lugo threw eight scoreless innings as the Kansas City Royals defeated the Houston Astros 2-0. The Royals have now won ...

STAT is tracking, day by day, what's happened in the words of science and health during the first months of the Trump ...

As Marty Makary nears the end of his first month on the job, the FDA Commissioner sat down for two interviews, offering ...

Phase 1 trial of TGW101 in advanced solid tumors is enrolling to assess safety and pharmacokinetics and define the maximum ...

Gosselies, Belgium Saturday, April 26, 2025, 16:00 Hrs [IST] ...

Prime Medicine’s modular editing tech may lower off-target risk, but key data and funding milestones remain ahead. Find out ...

To satisfy their fiduciary obligations, self-funded plan sponsors must take a proactive, informed approach to health plan ...

‘The face has a layer of fat that essentially stretches the skin. Ozempic results in rapid weight loss and does so very ...

Exagen (XGN) is a speculative buy with promising growth in diagnostics, new lupus/RA tests, and potential positive EBITDA by ...